Fibromyalgia Treatment: What Actually Works

By H. Rand Scott, MD — Medical Director, Newport Pain Management Reviewed and updated August 2026

Fibromyalgia is a chronic pain condition characterized by widespread musculoskeletal pain, fatigue, sleep disturbance, and cognitive symptoms ("fibro fog"). Current understanding places it firmly in the category of central sensitization disorders — the nervous system itself has become hypersensitive to pain signals, which is why standard anti-inflammatory approaches don't do much for it.

Treatment has advanced significantly in the past two decades. Three medications are now FDA-approved specifically for fibromyalgia, and the broader treatment approach — combining medication, exercise, sleep restoration, and cognitive-behavioral techniques — has strong evidence behind it. The goal is not cure but meaningful reduction of pain, restoration of function, and improvement of quality of life.

Effective treatment addresses multiple dimensions at once:

• Medications to reduce pain, improve sleep, and address associated symptoms.
• Graded aerobic exercise to improve cardiovascular fitness and reduce pain sensitivity.
• Sleep restoration, since poor sleep is both a symptom and an amplifier of fibromyalgia pain.
• Cognitive-behavioral techniques to manage the thought and behavior patterns that amplify pain.
• Stress management, given the strong link between stress and symptom severity.
• Education, so patients understand what the condition is and what makes it better or worse.

Treatment should be individualized. Some patients with mild symptoms need very little once they understand the condition; most benefit from a comprehensive plan.

Three medications are FDA-approved specifically for fibromyalgia:

• Pregabalin (Lyrica) — an antiseizure medication that reduces overactive pain signaling. FDA-approved for fibromyalgia in 2007.
• Duloxetine (Cymbalta) — a serotonin-norepinephrine reuptake inhibitor (SNRI). Works on pain signaling and also treats depression when present. FDA-approved for fibromyalgia in 2008.
• Milnacipran (Savella) — another SNRI, developed and approved specifically for fibromyalgia in 2009.

None of these produces complete relief for most patients, but each meaningfully reduces symptoms in a substantial fraction — and different patients respond to different agents, so it's often worth trying more than one.

Older tricyclic antidepressants — amitriptyline (Elavil) and cyclobenzaprine (Flexeril, which is structurally similar) — remain useful in low doses at bedtime. They aren't being used as antidepressants at those doses; they're being used for their sleep-promoting and pain-modulating effects. Side effects include daytime drowsiness, dry mouth, constipation, and weight gain. Some patients tolerate these well and get significant benefit; others don't tolerate them at all.

Simple analgesics — acetaminophen and NSAIDs (ibuprofen, naproxen) — provide modest benefit for the aches and stiffness. Because fibromyalgia isn't fundamentally an inflammatory condition, these don't work as well as they do in arthritis. But at modest doses, they can take the edge off.

Some medications commonly used for other pain conditions are specifically unhelpful — or harmful — in fibromyalgia:

• Opioids (morphine, oxycodone, hydrocodone) have consistently shown poor benefit in fibromyalgia and carry substantial risks. Long-term opioid use can also produce opioid-induced hyperalgesia, in which the medication itself increases pain sensitivity — the opposite of what a central sensitization patient needs.
• Tramadol has weak opioid activity and stronger effects on serotonin/norepinephrine; it can help some patients but is not first-line.
• Benzodiazepines (diazepam, alprazolam, lorazepam) disrupt the deep sleep architecture that fibromyalgia patients most need to restore.
• Corticosteroids systemically or intra-articularly aren't effective for fibromyalgia itself.

Exercise is one of the most reliably effective non-drug treatments for fibromyalgia. It's also one of the hardest for patients to start, because fibromyalgia makes exertion feel worse than it should — a phenomenon called post-exertional malaise.

The pattern that works: start well below what feels tolerable, and increase very gradually. Low-impact aerobic exercise — walking, cycling, swimming, water aerobics — is the best entry point. Warm-water pool exercise is particularly well-tolerated by many fibromyalgia patients because the buoyancy reduces joint load and the warmth reduces muscle guarding.

Aim for consistency over intensity. Every other day is a reasonable starting frequency. Session duration matters less than showing up. Over weeks and months, aerobic capacity improves and pain sensitivity typically decreases.

Add gentle stretching daily, especially before and after aerobic exercise. Physical therapy can help design a program that fits your pattern and includes techniques (heat, ice, massage, whirlpool, ultrasound, targeted electrical stimulation) that reduce pain enough to allow exercise to happen.

Fibromyalgia is characterized by disrupted deep-sleep architecture, and non-restorative sleep is one of its most consistent symptoms. Improving sleep is not a side project — it's core treatment.

Basic sleep hygiene applies with particular force: consistent bedtime and wake time, cool and dark bedroom, no screens for the last hour, no alcohol in the evening (it fragments sleep even when it initially helps you fall asleep), and no caffeine after early afternoon. If snoring, gasping, or partner reports of pauses in breathing are part of the picture, formal sleep study to evaluate for sleep apnea is warranted — untreated sleep apnea will defeat any other fibromyalgia treatment.

Cognitive-behavioral therapy (CBT) for chronic pain has the strongest evidence base of any psychological intervention in fibromyalgia. It's not about pretending the pain isn't real — it's about training the specific thought and behavior patterns that amplify pain and disability.

Related techniques with evidence in fibromyalgia include mindfulness-based stress reduction, biofeedback, and structured relaxation training. Which combination fits depends on the individual patient.

A subset of fibromyalgia patients doesn't respond adequately to standard treatment. For these patients, more specialized options are available:

• Low-dose naltrexone has emerging evidence in fibromyalgia and is used off-label at doses much lower than those used to treat opioid dependence.
• Ketamine infusions at sub-anesthetic doses have shown benefit for refractory fibromyalgia in some patients, particularly those with prominent central sensitization features. Newport Pain Management directs the KetaCure Ketamine Infusion Center specifically for patients in this category.
• Targeted trigger point injections can address specific muscle sites that are driving disproportionate pain.
• Multidisciplinary pain rehabilitation programs that combine medical, physical therapy, and psychological treatment in an intensive coordinated format produce durable improvements when standard outpatient care hasn't been enough.

Fibromyalgia is a real, biological condition. It's treatable — not curable, but genuinely treatable. The patients who do best combine the right medications with consistent exercise, sleep restoration, stress management, and honest ongoing communication with a treatment team experienced in central sensitization pain syndromes. To request an evaluation, call Newport Pain Management at (949) 759-8400.

This article is for general education and is not a substitute for individual medical advice.